Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andy A Toogood

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Endocrinology|July 25, 2007
Dopamine agonist therapy and cardiac valve dysfunctionMark Sherlock, Richard Steeds, Andy A Toogood
Heart (British Cardiac Society)|January 29, 2009
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to doMark Sherlock, Andy A Toogood, Richard Steeds
Clinical Endocrinology|June 22, 2016
ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centresMichael W O'Reilly, Raoul C Reulen, Saket Gupta, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Endocrinology|July 25, 2007
Dopamine agonist therapy and cardiac valve dysfunctionMark Sherlock, Richard Steeds, Andy A Toogood
Heart (British Cardiac Society)|January 29, 2009
Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to doMark Sherlock, Andy A Toogood, Richard Steeds
Clinical Endocrinology|June 22, 2016
ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centresMichael W O'Reilly, Raoul C Reulen, Saket Gupta, et al.
Pageof 1